Whoop is broadening its health platform once again. The company has announced that Whoop Advanced Labs can now be used without an active membership, turning its blood-testing service into a direct-to-consumer option.
The updated service also adds the Galleri test, developed by Grail, which is designed to look for signals associated with more than 50 cancer types. Rather than providing a diagnosis, the test is intended to flag a possible signal that can be discussed with a clinician and paired with standard medical screenings.
How the service works
Advanced Labs is powered by Quest Diagnostics and covers areas such as cardiovascular, metabolic, hormonal, and inflammatory health. Users can purchase a test, book a blood draw through the Whoop app, and visit a local clinic for collection. Whoop says at-home mobile draws are planned for select regions in the future.
Each test is ordered by a licensed healthcare provider, and the results are reviewed by a licensed clinician before appearing in the app with practical guidance. Whoop says pricing starts at around $150, and some purchases may be eligible for HSA or FSA reimbursement depending on the plan.
By removing the membership requirement, Whoop is opening its lab testing to a wider audience beyond its core wearable users. The move reflects a growing shift toward connected health services that combine biomarker data, digital tools, and personalized insights in one place. In the years ahead, this model could help make preventive health more accessible and data-driven.
